• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Santen Pharmaceutical Co Ltd

+ Add to Watchlist

SNPHF:US

Price not available for SNPHF:US

Snapshot for Santen Pharmaceutical Co Ltd (SNPHF)

Open: - Day's Range: - Volume: 0
Previous Close: 53.2500 52wk Range: 39.7500 - 53.2500 1-Yr Rtn: -

Stock Chart for SNPHF

No chart data available.
  • SNPHF:US 53.2500
  • 1M
  • 1Y
53.2500
Interactive SNPHF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNPHF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 21.8985
Relative P/E vs. SPX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 250.3890
Est. PEG Ratio 1.3332
Market Cap (M USD) 0.00
Shares Outstanding (M) 82.59
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.83%
Cash Dividend (JPY) 50.0000
Dividend Ex-Date 09/26/2014
5 Year Dividend Growth 4.95%
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNPHF

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for SNPHF

SANTEN PHARMACEUTICAL CO., LTD. produces and sells ophthalmic medicine. The Company manufactures a variety of products including eye drops and ointments. Santen Pharmaceutical also imports lenses and tools and equipment used by optometrists and produces anti-rheumatic drugs.

Akira KurokawaPresident/CEOSadatoshi FurukadoSenior Managing Exec Officer
Masamichi SatoManaging Executive OfficerJyrki LiljeroosExecutive Officer
More Company Profile & Key Executives for SNPHF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil